Human G37L1 full length protein-synthetic nanodisc FLP100250
Specifications
| 10µg / 50µg / 100µg |
Alternative names:
ET(B)R-LP-2, ETBR-LP-2, ETBRLP2
Description:
Human G37L1 full length protein-synthetic nanodisc
Background:
G-protein coupled receptor (PubMed:27072655). Has been shown to bind the neuroprotective and glioprotective factor prosaposin (PSAP), leading to endocytosis followed by an ERK phosphorylation cascade (PubMed:23690594). However, other studies have shown that prosaposin does not increase activity (PubMed:27072655, PubMed:28688853). It has been suggested that GPR37L1 is a constitutively active receptor which signals through the guanine nucleotide-binding protein G(s) subunit alpha (PubMed:27072655). Participates in the regulation of postnatal cerebellar development by modulating the Shh pathway (By similarity). Regulates baseline blood pressure in females and protects against cardiovascular stress in males (By similarity). Mediates inhibition of astrocyte glutamate transporters and reduction in neuronal N-methyl-D-aspartate receptor activity (By similarity).[UniProtKB/Swiss-Prot Function]
Protein families:
GPCR,Transmembrane,Druggable Genome,
Protein pathways:
GPCRDB Class A Rhodopsin-like,
Expression host:
HEK293
Target:
G37L1
Molecular weight:
The human full length G37L1 protein has a MW of 52.8kDa
Formulation / Reconstitution:
Lyophilized from nanodisc solubilization buffer (20 mM Tris-HCl, 150 mM NaCl, pH 8.0). Normally 5% - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Usage:
Research use only
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com
